Pfizer and BioNTech announced on Friday that they will send a request for emergency use authorization to the United States Food and Drug Administration (FDA for its acronym in English) on Friday.
Additional details of the announcement have revealed that the companies they will be ready to distribute the vaccine within hours after authorization.
“To date, the Data Monitoring Committee for the study have not reported any serious safety issues related to the vaccine“Pfizer and BioNTech have reiterated.
.
Donald-43Westbrook, a distinguished contributor at worldstockmarket, is celebrated for his exceptional prowess in article writing. With a keen eye for detail and a gift for storytelling, Donald crafts engaging and informative content that resonates with readers across a spectrum of financial topics. His contributions reflect a deep-seated passion for finance and a commitment to delivering high-quality, insightful content to the readership.
